GlassScriptPhysician profile
Mark William Thompson
NPI 1750733119
$2,696.91
in general payments reported to CMS, 2019-2025
22 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $239 · 2021: $275 · 2022: $200 · 2023: $154 · 2024: $324 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $706.41 | 2019 | |
| Smith+Nephew, INC. | $546.45 | 2019-2025 | Grafix Pl, Iodosorb Ointment 40g USA, Collagenase Santyl |
| Stryker Corporation | $528.83 | 2020-2025 | Flexband, Prostep, Ortholoc 3di |
| Pylant Medical | $203.50 | 2024-2025 | |
| Abbott Laboratories | $160.54 | 2019-2020 | |
| Ets Wound Care LLC | $59.93 | 2025 | Mirragen Advanced Wound Matrix |
| Organogenesis INC. | $59.06 | 2020-2022 | |
| Melinta Therapeutics, LLC | $55.89 | 2021-2022 | |
| Bioventus LLC | $45.53 | 2019-2021 | |
| Abbvie INC. | $42.80 | 2021-2022 | |
| Orthofix Medical, INC. | $40.45 | 2023-2024 | Physio-Stim |
| Integra Lifesciences Corporation | $37.60 | 2020-2021 | |
| Arthrosurface Incorporated | $30.87 | 2020 | |
| Assertio Therapeutics, INC. | $27.93 | 2020 | |
| Treace Medical Concepts, INC. | $26.60 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $25.60 | 2019 | |
| Heron Therapeutics, INC. | $20.93 | 2021 | |
| Kci USA, INC. | $20.67 | 2023 | 3m Cavilon, V.A.C. Dermatac, Kerramax Care |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.71 | 2025 | Cabtreo |
| Zyla Life Sciences, INC. | $13.82 | 2020 | |
| Horizon Therapeutics Plc | $13.13 | 2022 | |
| Depuy Synthes Sales INC. | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.